Aaron Mendelsohn - Aug 30, 2022 Form 4 Insider Report for Vivani Medical, Inc. (VANI)

Role
Director
Signature
/s/ Aaron Mendelsohn
Stock symbol
VANI
Transactions as of
Aug 30, 2022
Transactions value $
$0
Form type
4
Date filed
8/31/2022, 07:41 PM
Previous filing
Apr 29, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VANI Common Stock Other $0 +178K $0.00 178K Aug 30, 2022 Direct F1
transaction VANI Common Stock Other $0 +151K $0.00 151K Aug 30, 2022 Trusts F1, F2
transaction VANI Common Stock Other $0 +747K $0.00 747K Aug 30, 2022 See Footnote F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VANI Common Stock Option Other $0 +30.2K $0.00 30.2K Aug 30, 2022 Common Stock 30.2K $3.15 Direct F4
transaction VANI Common Stock Option Other $0 +30.2K $0.00 30.2K Aug 30, 2022 Common Stock 30.2K $3.15 Direct F4
transaction VANI Common Stock Option Other $0 +30.2K $0.00 30.2K Aug 30, 2022 Common Stock 30.2K $3.15 Direct F4
transaction VANI Warrants Other $0 +25.9K $0.00 25.9K Aug 30, 2022 Common Stock 25.9K $3.15 See Footnote F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022.
F2 Represents five trusts, each one established for a separate grandchild of the Reporting Person, each trust owning an aggregate of 30,186 shares of common stock, all trusts with the same terms, over which the Reporting Person has voting and dispositive authority.
F3 Represents shares of common stock owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of the limited liability company and therefore 149,478 shares of common stock held by the limited liability company, which are beneficially owned by other members of the limited liability company.
F4 Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022.
F5 Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022.
F6 Represents shares of common stock underlying a warrant owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of the limited liability company and therefore 5,185 shares of common stock held by the limited liability company, which are beneficially owned by other members of the limited liability company.